David S Utley

Redwood City, CA, United States of America

David S Utley

This inventor holds 135 USPTO granted patents and 26 published patent applications, plus 7 CIPO patents and 18 EPO patents, primarily in Behavioral Change Technology (CPC class A61B18-1492). Top assignees: Curon Medical, Inc., Mederi Therapeutics, Inc., Covidien LP. Active years: 2000-2024.

USPTO Granted Patents = 135 

% Patents Active = 59.3

 

 

Average Co-Inventor Count = 3.7

ph-index = 54

Forward Citations = 15,702(Granted Patents)

Forward Citations (Not Self Cited) = 13,996(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • San Carlos, CA (US) (2000 - 2015)
  • Redwood, CA (US) (2006 - 2019)
  • Redwood City, CA (US) (2002 - 2024)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Smoking Cessation
Behavioral Change
Breath Sensor
Gastrointestinal Ablation
Medical Device Monitoring
Electrode Devices
Expandable Structures
Surgical Apparatus
Physiologic Characteristics
User Interface
Extracorporeal Devices
Support Structures
135 patents (USPTO):Explore Patents

Title: David S Utley: Innovator and Inventor Extraordinaire

Introduction:

David S Utley, a prolific inventor based in Redwood City, CA, has made significant contributions to the fields of behavioral modification and cessation programs. With an impressive portfolio of 127 patents, Utley's inventive genius and expertise have been instrumental in developing systems and methods to assist patients in modifying and terminating undesired behaviors. Let's explore his latest patents, career highlights, and collaborations in more detail.

Latest Patents:

Among his latest patents, two noteworthy inventions stand out. The first patent is titled "Systems and methods for quantification of, and prediction of smoking behavior." This invention involves the development of patient devices, including carbon monoxide blood level sensors, which prompt self-testing, analyze results, and log data. These devices are integrated into a networked system and targeted at smoking cessation programs.

The second patent, titled "Systems and methods for assisting individuals in a behavioral-change program," focuses on enhancing electronic interactions between a behavioral-modification program and users. Utley's invention includes providing customized content specific to each user, allowing for coach-counselor assistance or automated content delivery. This innovation holds great potential for optimizing the effectiveness of behavioral-change programs.

Career Highlights:

Throughout his career, David S Utley has played an integral role in shaping the medical device industry. He has worked with renowned companies such as Curon Medical, Inc., where he contributed to the development of cutting-edge medical technologies. Utley's invaluable contributions have also been recognized during his tenure at Mederi Therapeutics, Inc., where he excelled as a visionary inventor and innovator.

Collaborations:

Utley's collaborations are a testament to his ability to partner with like-minded individuals in pursuit of common goals. Notably, he has worked closely with esteemed colleagues such as John W Gaiser and Jay Qin. These partnerships have undoubtedly nurtured a rich environment for innovative thinking and have led to the successful implementation of many groundbreaking ideas.

Conclusion:

David S Utley's impressive collection of patents and his unwavering dedication to behavioral modification and cessation programs have had a lasting impact on the medical field. Through his innovative devices and methods, Utley continues to provide individuals with tools to overcome undesirable behaviors, particularly focusing on smoking cessation. Utley's contributions and collaborations demonstrate his commitment to improving lives through inventive solutions. As an esteemed inventor, he continues to inspire the next generation of innovators in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…